Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Mycobacterium tuberculosis infection interferes with HIV vaccination in mice.

Ignatowicz L, Mazurek J, Leepiyasakulchai C, Sköld M, Hinkula J, Källenius G, Pawlowski A.

PLoS One. 2012;7(7):e41205. doi: 10.1371/journal.pone.0041205. Epub 2012 Jul 23.

PMID:
22848444
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A novel tuberculosis DNA vaccine in an HIV-1 p24 protein backbone confers protection against Mycobacterium tuberculosis and simultaneously elicits robust humoral and cellular responses to HIV-1.

Li X, Xu W, Xiong S.

Clin Vaccine Immunol. 2012 May;19(5):723-30. doi: 10.1128/CVI.05700-11. Epub 2012 Mar 29.

PMID:
22461526
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells.

Hinkula J, Walther-Jallow L, Laurén A, Mäkitalo B, Oberg M, Wahren B, Fenyö EM, Spetz AL.

Vaccine. 2009 Oct 30;27(46):6424-31. doi: 10.1016/j.vaccine.2009.06.016. Epub 2009 Jun 21.

PMID:
19549607
[PubMed - indexed for MEDLINE]
4.

Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice.

Ranganathan UD, Larsen MH, Kim J, Porcelli SA, Jacobs WR Jr, Fennelly GJ.

Vaccine. 2009 Dec 10;28(1):152-61. doi: 10.1016/j.vaccine.2009.09.087. Epub 2009 Oct 4.

PMID:
19808028
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice.

Yuan W, Dong N, Zhang L, Liu J, Lin S, Xiang Z, Qiao H, Tong W, Qin C.

Vaccine. 2012 Mar 23;30(14):2490-7. doi: 10.1016/j.vaccine.2011.06.029. Epub 2011 Jun 23.

PMID:
21704108
[PubMed - indexed for MEDLINE]
6.

HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses.

Sakaue G, Hiroi T, Nakagawa Y, Someya K, Iwatani K, Sawa Y, Takahashi H, Honda M, Kunisawa J, Kiyono H.

J Immunol. 2003 Jan 1;170(1):495-502.

PMID:
12496436
[PubMed - indexed for MEDLINE]
Free Article
7.

Detection of polyfunctional Mycobacterium tuberculosis-specific T cells and association with viral load in HIV-1-infected persons.

Day CL, Mkhwanazi N, Reddy S, Mncube Z, van der Stok M, Klenerman P, Walker BD.

J Infect Dis. 2008 Apr 1;197(7):990-9. doi: 10.1086/529048.

PMID:
18419535
[PubMed - indexed for MEDLINE]
Free Article
8.

High-sensitive and rapid detection of Mycobacterium tuberculosis infection by IFN-gamma release assay among HIV-infected individuals in BCG-vaccinated area.

Jiang W, Shao L, Zhang Y, Zhang S, Meng C, Xu Y, Huang L, Wang Y, Wang Y, Weng X, Zhang W.

BMC Immunol. 2009 May 28;10:31. doi: 10.1186/1471-2172-10-31.

PMID:
19476627
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis.

Coler RN, Campos-Neto A, Ovendale P, Day FH, Fling SP, Zhu L, Serbina N, Flynn JL, Reed SG, Alderson MR.

J Immunol. 2001 May 15;166(10):6227-35.

PMID:
11342645
[PubMed - indexed for MEDLINE]
Free Article
11.

[Novel vaccines against M. tuberculosis].

Okada M.

Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.

PMID:
17240920
[PubMed - indexed for MEDLINE]
12.

Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapy.

Jin X, Ramanathan M Jr, Barsoum S, Deschenes GR, Ba L, Binley J, Schiller D, Bauer DE, Chen DC, Hurley A, Gebuhrer L, El Habib R, Caudrelier P, Klein M, Zhang L, Ho DD, Markowitz M.

J Virol. 2002 Mar;76(5):2206-16.

PMID:
11836398
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Newcastle disease virus expressing human immunodeficiency virus type 1 envelope glycoprotein induces strong mucosal and serum antibody responses in Guinea pigs.

Khattar SK, Samal S, Devico AL, Collins PL, Samal SK.

J Virol. 2011 Oct;85(20):10529-41. doi: 10.1128/JVI.05050-11. Epub 2011 Aug 17.

PMID:
21849467
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice.

Geluk A, van den Eeden SJ, van Meijgaarden KE, Dijkman K, Franken KL, Ottenhoff TH.

Vaccine. 2012 Dec 14;30(52):7513-21. doi: 10.1016/j.vaccine.2012.10.045. Epub 2012 Oct 24.

PMID:
23103299
[PubMed - indexed for MEDLINE]
15.

Maternal immune status influences HIV-specific immune responses in pups after DNA prime protein boost using mucosal adjuvant.

Bråve A, Johansen K, Palma P, Benthin R, Hinkula J.

Vaccine. 2008 Nov 5;26(47):5957-66. doi: 10.1016/j.vaccine.2008.08.060. Epub 2008 Sep 16.

PMID:
18801400
[PubMed - indexed for MEDLINE]
16.

Induction of primary virus-cross-reactive human immunodeficiency virus type 1-neutralizing antibodies in small animals by using an alphavirus-derived in vivo expression system.

Dong M, Zhang PF, Grieder F, Lee J, Krishnamurthy G, VanCott T, Broder C, Polonis VR, Yu XF, Shao Y, Faix D, Valente P, Quinnan GV Jr.

J Virol. 2003 Mar;77(5):3119-30.

PMID:
12584337
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis.

Adekambi T, Ibegbu CC, Kalokhe AS, Yu T, Ray SM, Rengarajan J.

PLoS One. 2012;7(4):e36046. doi: 10.1371/journal.pone.0036046. Epub 2012 Apr 24.

PMID:
22545156
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Evaluation of envelope vaccines derived from the South African subtype C human immunodeficiency virus type 1 TV1 strain.

Lian Y, Srivastava I, Gómez-Román VR, Zur Megede J, Sun Y, Kan E, Hilt S, Engelbrecht S, Himathongkham S, Luciw PA, Otten G, Ulmer JB, Donnelly JJ, Rabussay D, Montefiori D, van Rensburg EJ, Barnett SW.

J Virol. 2005 Nov;79(21):13338-49.

PMID:
16227256
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Construction, biological activity, and immunogenicity of synthetic envelope DNA vaccines based on a primary, CCR5-tropic, early HIV type 1 isolate (BX08) with human codons.

Corbet S, Vinner L, Hougaard DM, Bryder K, Nielsen HV, Nielsen C, Fomsgaard A.

AIDS Res Hum Retroviruses. 2000 Dec 10;16(18):1997-2008.

PMID:
11153083
[PubMed - indexed for MEDLINE]
20.

Serum antibodies to HIV-1 in recombinant vaccinia virus recipients boosted with purified recombinant gp160. NIAID AIDS Vaccine Clinical Trials Network.

Montefiori DC, Graham BS, Kliks S, Wright PF.

J Clin Immunol. 1992 Nov;12(6):429-39.

PMID:
1287035
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk